Vælg din region

Vælg den region, der bedst passer til din placering eller dine præferencer.

International

Vælg dit webstedssprog

Denne indstilling styrer sproget for brugergrænsefladen, inklusive knapper, menuer og al tekst på webstedet. Vælg dit foretrukne sprog for den bedste browsingoplevelse.

Vælg sprog for jobannoncer

Vælg de sprog for jobannoncer, du vil se. Denne indstilling afgør, hvilke jobannoncer der vises for dig.

Marie Skłodowska-Curie ITN-European Joint Doctorate - MOGLYNET

Milano, Italien

Besøg website

Om arbejdsgiveren

We are the MOGLYNET-PhD programme in drug discovery and development.

horizon-ibidi The Horizon 2020 MSCA joint doctoral project MoGglyNet (“Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study”) is run by a Consortium of Universities in cooperation with Industries and Associations operating in the Pharma sector with the aim to offer an innovative PhD level training in Drug Discovery and Development to 12 Early Stage Researchers.

The MOGLYNET PhD programme aims to define a new joint PhD educational model in Drug Discovery and Development and to promote institutional cooperation and mobility.

An active contribution of Industry in training activities is an important feature of the programme. The research methodologies and approaches proposed by the MOGLYNET consortium are strongly multidisciplinary and will involve a number of different state-of-the-art technologies and methodologies: Computational chemistry, Chemical synthesis; Bioanalytics and biophysics; In vitro biological evaluation; In vivo studies; Imaging; Metabolomics; Proteomics; Oxidative stress.